IRGQ-mediated autophagy in MHC class I quality control promotes tumor immune evasion

被引:4
|
作者
Herhaus, Lina [1 ]
Gestal-Mato, Uxia [1 ]
Eapen, Vinay V. [2 ,3 ]
Macinkovic, Igor [1 ,4 ]
Bailey, Henry J. [1 ,5 ]
Prieto-Garcia, Cristian [1 ]
Misra, Mohit [1 ,5 ]
Jacomin, Anne-Claire [1 ]
Ammanath, Aparna Viswanathan [1 ]
Bagaric, Ivan [1 ]
Michaelis, Jolina [1 ]
Vollrath, Joshua [1 ,5 ,6 ]
Bhaskara, Ramachandra M. [1 ,5 ]
Buendgen, Georg [7 ]
Covarrubias-Pinto, Adriana [1 ]
Husnjak, Koraljka [1 ]
Zoeller, Jonathan [6 ]
Gikandi, Ajami [2 ]
Ribicic, Sara [1 ]
Bopp, Tobias [7 ]
van Noort, Gerbrand J. van der Heden [8 ]
Langer, Julian D. [6 ]
Weigert, Andreas [4 ]
Harper, J. Wade [3 ]
Mancias, Joseph D. [2 ]
Dikic, Ivan [1 ,5 ,6 ]
机构
[1] Goethe Univ Frankfurt, Inst Biochem 2, Med Fac, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
[2] Harvard Inst Med, Dana Farber Canc Inst, Dept Radiat Oncol, Div Radiat & Genome Stabil, 450 Brookline Ave, Boston, MA 02215 USA
[3] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA
[4] Goethe Univ, Inst Biochem 1, Sch Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
[5] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Riedberg Campus,Max von Laue Str 15, D-60438 Frankfurt, Germany
[6] Goethe Univ Frankfurt, Max Planck Inst Biophys, Riedberg Campus, D-60438 Frankfurt, Germany
[7] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Mainz, Germany
[8] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands
关键词
PROTEIN; CANCER; DEGRADATION; HOMEOSTASIS; EXPRESSION; MOLECULES; MECHANISM; DYNAMICS; MODELS; EFFLUX;
D O I
10.1016/j.cell.2024.09.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The autophagy-lysosome system directs the degradation of a wide variety of cargo and is also involved in tumor progression. Here, we show that the immunity-related GTPase family Q protein (IRGQ), an uncharacterized protein to date, acts in the quality control of major histocompatibility complex class I (MHC class I) molecules. IRGQ directs misfolded MHC class I toward lysosomal degradation through its binding mode to GABARAPL2 and LC3B. In the absence of IRGQ, free MHC class I heavy chains do not only accumulate in the cell but are also transported to the cell surface, thereby promoting an immune response. Mice and human patients suffering from hepatocellular carcinoma show improved survival rates with reduced IRGQ levels due to increased reactivity of CD8+ T cells toward IRGQ knockout tumor cells. Thus, we reveal IRGQ as a regulator of MHC class I quality control, mediating tumor immune evasion.
引用
收藏
页码:7285 / 7302.e29
页数:48
相关论文
共 38 条
  • [31] Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inibitor Response
    Montesion, Meagan
    Murugesan, Karthikeyan
    Jin, Dexter X.
    Sharaf, Radwa
    Sanchez, Nora
    Guria, Ameet
    Minker, Max
    Li, Gerald
    Fisher, Virginia
    Sokol, Ethan S.
    Pavlick, Dean C.
    Moore, Jay A.
    Braly, Alan
    Singal, Gaurav
    Fabrizio, David
    Comment, Leah A.
    Rizvi, Naiyer A.
    Alexander, Brian M.
    Frampton, Garrett M.
    Hegde, Priti S.
    Albacker, Lee A.
    CANCER DISCOVERY, 2021, 11 (02) : 282 - 292
  • [32] HHV-7 U21 exploits Golgi quality control carriers to reroute class I MHC molecules to lysosomes
    Dirck, Aaron T.
    Whyte, Melissa L.
    Hudson, Amy W.
    MOLECULAR BIOLOGY OF THE CELL, 2020, 31 (03) : 196 - 208
  • [33] Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells
    Sun, Ting
    Li, Yanyan
    Yang, Wei
    Wu, Haibin
    Li, Xuetao
    Huang, Yulun
    Zhou, Youxin
    Du, Ziwei
    JOURNAL OF CANCER, 2019, 10 (23): : 5638 - 5645
  • [34] Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis
    Zakharova, Liudmila A.
    Khegai, Igor I.
    Sharova, Natalia P.
    Melnikova, Victoria I.
    Karpova, Yaroslava D.
    Astakhova, Tatiana M.
    Popova, Nelly A.
    Ivanova, Liudmila N.
    CELLULAR IMMUNOLOGY, 2011, 271 (02) : 385 - 391
  • [35] EZh2Y641F mutations co-operate with Stat3 to regulate MHC class I antigen processing and alter the tumor immune response in melanoma
    Zimmerman, Sarah M.
    Nixon, Samantha J.
    Chen, Pei Yu
    Raj, Leela
    Smith, Sofia R.
    Paolini, Rachel L.
    Lin, Phyo Nay
    Souroullas, George P.
    ONCOGENE, 2022, 41 (46) : 4983 - 4993
  • [36] Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinoma
    Chung, Hye Won
    Lim, Jong-Baeck
    CANCER SCIENCE, 2011, 102 (09) : 1673 - 1679
  • [37] MHC Class I-Restricted TCR-Transgenic CD4+T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo
    Schober, Sebastian J.
    Thiede, Melanie
    Gassmann, Hendrik
    Prexler, Carolin
    Xue, Busheng
    Schirmer, David
    Wohlleber, Dirk
    Stein, Stefanie
    Grunewald, Thomas G. P.
    Busch, Dirk H.
    Richter, Guenther H. S.
    Burdach, Stefan E. G.
    Thiel, Uwe
    CELLS, 2020, 9 (07) : 1 - 15
  • [38] Physical and Functional Interaction of Transmembrane Thioredoxin-related Protein with Major Histocompatibility Complex Class I Heavy Chain: Redox-based Protein Quality Control and Its Potential Relevance to Immune Responses
    Matsuo, Yoshiyuki
    Masutani, Hiroshi
    Son, Aoi
    Kizaka-Kondoh, Shinae
    Yodoi, Junji
    MOLECULAR BIOLOGY OF THE CELL, 2009, 20 (21) : 4552 - 4562